AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1–Bcl-6 axis-mediated B-cell differentiation
Abstract Absent in melanoma 2 (AIM2) has been reported to be a component of inflammasomes in innate immune cells. Surprisingly, AIM2 is expressed by B cells, and higher AIM2 expression is observed in the B cells from lupus patients. To date, the inflammasome-independent function of AIM2 in B cells r...
Main Authors: | Ming Yang, Di Long, Longyuan Hu, Zhidan Zhao, Qianwen Li, Yunkai Guo, Zhenghao He, Ming Zhao, Liwei Lu, Fen Li, Hai Long, Haijing Wu, Qianjin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00725-x |
Similar Items
-
The IL‐21‐TET2‐AIM2‐c‐MAF pathway drives the T follicular helper cell response in lupus‐like disease
by: Haijing Wu, et al.
Published: (2022-03-01) -
The pathological role of B cells in systemic lupus erythematosus: From basic research to clinical
by: Yu Feng, et al.
Published: (2020-02-01) -
Abnormal lower expression of GPR183 in peripheral blood T and B cell subsets of systemic lupus erythematosus patients
by: Mingming Zhao, et al.
Published: (2022-09-01) -
Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients
by: Yongjian Chen, et al.
Published: (2020-05-01) -
Blimp-1 Contributes to the Development and Function of Regulatory B Cells
by: Ying-Hsiu Wang, et al.
Published: (2019-08-01)